Skip to content

Auricular Acupuncture vs. Sham Procedure for Pain Control After Knee Arthroplasty

Auricular Acupuncture (AA) vs. Sham AA Procedure for Pain Control After Elective Knee Arthroplasty - a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03114449
Acronym
AA_K-TEP
Enrollment
150
Registered
2017-04-14
Start date
2012-10-31
Completion date
2013-12-31
Last updated
2017-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Aim of the study To investigate whether auricular acupuncture (AA) will reduce postoperative pain and analgesic requirement in comparison with sham AA in patients after elective knee arthroplasty Design Prospective randomized controlled blinded clinical trial Participants: * Patients \< 80 und \> 50 years old * scheduled for knee arthroplasty under general anesthesia with \< 120 minutes duration * Without previous opioid medication * Able to give informed consent Outcome measures * Postoperative analgesic requirement * Incidence of side effects * Physiological parameters

Interventions

DEVICEAuricular acupuncture

Auricular acupuncture with indwelling fixed needles at specific AA points

Sham auricular acupuncture (AA) with indwelling fixed needles applied at non-AA points

Sponsors

Naemi-Wilke-Stift Guben Hospital - Anesthesia Services
CollaboratorOTHER
University Medicine Greifswald
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with an American Society of Anesthesiologists physical status of I to III scheduled for elective knee arthroplasty under general anesthesia 2. Surgery time does not exceed 120 minutes 3. Patients without previous opioid medication 4. Patients ranged 50-80 years old 5. Patients who have given written informed consent

Exclusion criteria

1. Recidivist alcoholics 2. Local auricular skin infection 3. Age \< 50 and \> 80 years 4. Surgery time more than 120 minutes 5. Intraoperative complications (bleeding, required blood transfusion more than 6 units of packed cells, cardiovascular instability, required catecholamines) 6. Patients who consumed opioid medication at least 6 months before surgery 7. Patients with prosthetic or damaged cardiac valves, intracardiac and intravascular shunts, hypertrophic cardiomyopathy and mitral valve prolaps (risk of bacterial endocarditis according to guidelines of AHA) 8. Patients who are unable to understand the consent form 9. History of psychiatric disease

Design outcomes

Primary

MeasureTime frameDescription
Postoperative requirement of analgesic tilidine (measured in mg)Six days following surgeryRequirement of opioid analgesic tilidin

Secondary

MeasureTime frameDescription
Side effects of analgesicsSix days following surgeryIncidence of nausea and vomiting
heart rate12 hours after surgeryheart rate
blood pressure12 hours following surgeryblood pressure
Patients' satisfaction with the treatment of postoperative pain using NRS-5 (where 1=excellent; 5=very bad)12 hours following surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026